ID   Mel 12.07
AC   CVCL_ZD06
SY   MEL12.07; 12.07
DR   cancercelllines; CVCL_ZD06
DR   Wikidata; Q98127216
RX   PubMed=27350335;
CC   From: Leiden University Medical Center; Leiden; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:1424; CAD; Simple; p.Arg1854Gln (c.5561G>A); ClinVar=VCV001481207; Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:3330; EML1; Simple; p.Arg64Trp (c.190C>T); Zygosity=Heterozygous (PubMed=27350335).
CC   Sequence variation: Mutation; HGNC; HGNC:8761; PDCD10; Simple; p.Pro28Ser (c.82C>T); Zygosity=Homozygous (PubMed=27350335).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZD03 ! Mel 04.01
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
RX   PubMed=27350335; DOI=10.1038/nature18945;
RA   Verdegaal E.M.E., de Miranda N.F.C.C., Visser M., Harryvan T.,
RA   van Buuren M.M., Andersen R.S., Hadrup S.R., van der Minne C.E.,
RA   Schotte R., Spits H., Haanen J.B.A.G., Kapiteijn E.H.W.,
RA   Schumacher T.N., van der Burg S.H.;
RT   "Neoantigen landscape dynamics during human melanoma-T cell
RT   interactions.";
RL   Nature 536:91-95(2016).
//